207 related articles for article (PubMed ID: 10972475)
1. Cholecystokinin modulates both the development and the expression of behavioral sensitization to amphetamine in the rat.
Wunderlich GR; DeSousa NJ; Vaccarino FJ
Psychopharmacology (Berl); 2000 Aug; 151(2-3):283-90. PubMed ID: 10972475
[TBL] [Abstract][Full Text] [Related]
2. Effect of CCK1 and CCK2 receptor blockade on amphetamine-stimulated exploratory behavior and sensitization to amphetamine.
Alttoa A; Harro J
Eur Neuropsychopharmacol; 2004 Aug; 14(4):324-31. PubMed ID: 15163443
[TBL] [Abstract][Full Text] [Related]
3. Cholecystokinin modulation of locomotor behavior in rats is sensitized by chronic amphetamine and chronic restraint stress exposure.
Wunderlich GR; Rotzinger S; Bush DE; DeSousa NJ; Vaccarino FJ
Brain Res; 2004 Mar; 1001(1-2):95-107. PubMed ID: 14972658
[TBL] [Abstract][Full Text] [Related]
4. The expression of behavioral sensitization to amphetamine: role of CCK(A) receptors.
DeSousa NJ; Wunderlich GR; De Cabo C; Vaccarino FJ
Pharmacol Biochem Behav; 1999 Jan; 62(1):31-7. PubMed ID: 9972842
[TBL] [Abstract][Full Text] [Related]
5. Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway.
Crawley JN
J Neurosci; 1992 Sep; 12(9):3380-91. PubMed ID: 1527584
[TBL] [Abstract][Full Text] [Related]
6. Differentially altered mGluR1 and mGluR5 mRNA expression in rat caudate nucleus and nucleus accumbens in the development and expression of behavioral sensitization to repeated amphetamine administration.
Mao L; Wang JQ
Synapse; 2001 Sep; 41(3):230-40. PubMed ID: 11418936
[TBL] [Abstract][Full Text] [Related]
7. Differential involvement of CCK-A and CCK-B receptors in the regulation of locomotor activity in the mouse.
Vasar E; Harro J; Lang A; Pôld A; Soosaar A
Psychopharmacology (Berl); 1991; 105(3):393-9. PubMed ID: 1798834
[TBL] [Abstract][Full Text] [Related]
8. Evidence for the contribution of CCKB receptor mechanisms to individual differences in amphetamine-induced locomotion.
Higgins GA; Sills TL; Tomkins DM; Sellers EM; Vaccarino FJ
Pharmacol Biochem Behav; 1994 Aug; 48(4):1019-24. PubMed ID: 7972279
[TBL] [Abstract][Full Text] [Related]
9. A single social defeat induces short-lasting behavioral sensitization to amphetamine.
de Jong JG; Wasilewski M; van der Vegt BJ; Buwalda B; Koolhaas JM
Physiol Behav; 2005 Jan; 83(5):805-11. PubMed ID: 15639166
[TBL] [Abstract][Full Text] [Related]
10. Changes in motor activity and forebrain [propionyl-3H]propionylated-CCK-8 binding in mice after repeated administration of drugs affecting cholecystokinin receptors.
Vasar E; Stephenson JD; Meldrum BS
Eur J Pharmacol; 1991 Sep; 202(3):385-90. PubMed ID: 1748160
[TBL] [Abstract][Full Text] [Related]
11. Opposing effects of two CCK(B) agonists on the retrieval phase of a two-trial memory task after systemic injection in the rat.
Léna I; Simon H; Roques BP; Daugé V
Neuropharmacology; 1999 Apr; 38(4):543-53. PubMed ID: 10221758
[TBL] [Abstract][Full Text] [Related]
12. Effects of amphetamine exposure during adolescence on behavior and prelimbic cortex neuron activity in adulthood.
Sherrill LK; Gulley JM
Brain Res; 2018 Sep; 1694():111-120. PubMed ID: 29792867
[TBL] [Abstract][Full Text] [Related]
13. Individual Differences in Amphetamine Locomotor Sensitization are Accompanied with Changes in Dopamine Release and Firing Pattern in the Dorsolateral Striatum of Rats.
Gatica RI; Aguilar-Rivera MÍ; Azocar VH; Fuentealba JA
Neuroscience; 2020 Feb; 427():116-126. PubMed ID: 31874242
[TBL] [Abstract][Full Text] [Related]
14. Effects of co-administration of the GABAB receptor agonist baclofen and a positive allosteric modulator of the GABAB receptor, CGP7930, on the development and expression of amphetamine-induced locomotor sensitization in rats.
Cedillo LN; Miranda F
Pharmacol Rep; 2013; 65(5):1132-43. PubMed ID: 24399709
[TBL] [Abstract][Full Text] [Related]
15. Cholecystokinin increases extracellular dopamine overflow in the anterior nucleus accumbens via CCK(B) receptors in the VTA assessed by in vivo voltammetry.
Reum T; Schäfer U; Marsden CA; Fink H; Morgenstern R
Neuropeptides; 1997 Feb; 31(1):82-8. PubMed ID: 9574843
[TBL] [Abstract][Full Text] [Related]
16. Modulatory role for CCK-B antagonists in Parkinson's disease.
Boyce S; Rupniak NM; Tye S; Steventon MJ; Iversen SD
Clin Neuropharmacol; 1990 Aug; 13(4):339-47. PubMed ID: 1976438
[TBL] [Abstract][Full Text] [Related]
17. G protein-coupled receptor signaling in VTA dopaminergic neurons bidirectionally regulates the acute locomotor response to amphetamine but does not affect behavioral sensitization.
Runegaard AH; Dencker D; Wörtwein G; Gether U
Neuropharmacology; 2019 Dec; 161():107663. PubMed ID: 31173760
[TBL] [Abstract][Full Text] [Related]
18. Response of the gastric vagal afferent activity to cholecystokinin in rats lacking type A cholecystokinin receptors.
Kurosawa M; Bucinskaite V; Taniguchi T; Miyasaka K; Funakoshi A; Lundeberg T
J Auton Nerv Syst; 1999 Jan; 75(1):51-9. PubMed ID: 9935269
[TBL] [Abstract][Full Text] [Related]
19. Amphetamine-induced zif268 mRNA expression in the medial posterior nucleus accumbens in cholecystokinin-A receptor mutant rats.
Shilling PD; Feifel D; Kelsoe JR
Neurosci Lett; 2000 Mar; 281(1):17-20. PubMed ID: 10686405
[TBL] [Abstract][Full Text] [Related]
20. Maternal immune activation in late gestation enhances locomotor response to acute but not chronic amphetamine treatment in male mice offspring: role of the D1 receptor.
Zager A; Mennecier G; Palermo-Neto J
Behav Brain Res; 2012 Jun; 232(1):30-6. PubMed ID: 22487249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
